Drugs / Injectable albumin platelets rich fibrin
Injectable albumin platelets rich fibrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06842277 | Feb → Dec 2025 overdue | mouth disorder | Cairo University | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Injectable albumin platelets rich fibrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06842277 ↗ |
| Known as | Alb-PRF | “Then preparation of injectable Alb-PRF, 10ml of intravenous blood will be withdrawn from antecubital region and will be centrifuged using plastic tubes at 700g for 8 minutes.” NCT06842277 ↗ |
| Known as | albumin PRF | “Albumin-PRF is an efficient treatment of deficient interdental papilla.” NCT06842277 ↗ |